Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

157
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
157

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating Somatic and Germline Pharmacogenomics for Therapeutic Decisions in Precision Oncology.

JCO precision oncology·2026
Same author

Real-World Weight Loss Is Associated With a Reduction in Cancer Risk.

Obesity (Silver Spring, Md.)·2026
Same author

The alternative splicing landscape of hepatocellular carcinoma and its potential for HCC detection.

Hepatology communications·2025
Same author

Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL study.

Clinical kidney journal·2025
Same author

An Integrated Interprofessional Continuing Medical Education and Quality Improvement Initiative to Address Cardiovascular and Renal Risk in Patients with Type 2 Diabetes in Community-Based Primary Care Practices.

Journal of CME·2025
Same author

Change in urine albumin-to-creatinine ratio and clinical outcomes in patients with chronic kidney disease and type 2 diabetes.

BMJ open diabetes research & care·2025

Related Experiment Video

Updated: Jun 30, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

An interpretable predictive deep learning platform for pediatric metabolic diseases.

Hamed Javidi1,2,3, Arshiya Mariam1,3, Lina Alkhaled3,4

  • 1Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, United States.

Journal of the American Medical Informatics Association : JAMIA
|March 18, 2024
PubMed
Summary
This summary is machine-generated.

Early detection of pediatric metabolic diseases like type 2 diabetes is crucial. A deep learning model using longitudinal data, including BMI trajectories, accurately predicts disease onset, improving upon models using only recent data.

Keywords:
deep learningelectronic health record (EHR)interpretable machine learninglongitudinal datapediatric disease predictiontype 2 diabetes

More Related Videos

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data
09:34

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data

Published on: September 25, 2021

4.0K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.6K

Related Experiment Videos

Last Updated: Jun 30, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K
A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data
09:34

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data

Published on: September 25, 2021

4.0K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.6K

Area of Science:

  • Pediatric Endocrinology
  • Computational Health Science
  • Machine Learning in Medicine

Background:

  • Childhood metabolic diseases, including prediabetes, type 2 diabetes (T2D), and metabolic syndrome, are rising globally.
  • These conditions significantly impair quality of life and increase the risk of chronic comorbidities.
  • Effective early detection tools are urgently needed for timely intervention in pediatric populations.

Purpose of the Study:

  • To develop and validate an interpretable deep learning model for predicting the onset of prediabetes, T2D, and metabolic syndrome in children.
  • To assess the utility of longitudinal clinical data, including body mass index (BMI) trajectories, for improving predictive accuracy.

Main Methods:

  • Utilized interpretable deep learning on electronic health record data from a large integrated health system.
  • Included longitudinal clinical measurements, demographical data, and diagnosis codes for a cohort of 49,517 children (aged 2-18) with overweight or obesity.
  • Compared model performance using longitudinal data versus models relying solely on the most recent BMI data.

Main Results:

  • The model achieved area under the receiver operating characteristic curve (AUC) accuracies of up to 0.87 for T2D, 0.79 for metabolic syndrome, and 0.79 for prediabetes.
  • Incorporating longitudinal data significantly improved AUCs by 11-13% compared to models using only the most recent BMI.
  • BMI trajectories were identified as a consistently influential feature in the predictive model.

Conclusions:

  • Longitudinal data analysis, specifically BMI trajectories, provides a more comprehensive patient health characterization and enhances predictive accuracy for pediatric metabolic diseases.
  • Interpretable deep learning models leveraging historical data offer a promising approach for early detection and intervention.
  • This methodology highlights the importance of considering temporal health trends over static measurements for improved clinical prediction.